OLA1, an Obg-like ATPase, suppresses antioxidant response via nontranscriptional mechanisms

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 36, 2009, Pages 15356-15361

  Zhang, Jiawei ^a   Rubio, Valentina ^a   Lieberman, Michael W ^a   Shi, Zheng Zheng ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Drug target; Oxidative stress; Posttranslational regulation

Indexed keywords

ANTIOXIDANT; CYCLOHEXIMIDE; CYTOTOXIC AGENT; DIAMIDE; GLUTATHIONE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TERT BUTYL HYDROPEROXIDE; THIOL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR OLA 1; UNCLASSIFIED DRUG;

ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME REPRESSION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN TARGETING;

ADENOSINE TRIPHOSPHATASES; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; DIAMIDE; DNA PRIMERS; GLUTATHIONE; GTP-BINDING PROTEINS; HELA CELLS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TERT-BUTYLHYDROPEROXIDE;

EID: 70349318685     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0907213106     Document Type: Article

References (42)

1. Seis H (1991) Oxidative Stress: Oxidants and Antioxidants. (Academic, London).
2. Valko M, et al. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84. (Pubitemid 44566469)
3. Hensley K, Floyd RA (2002) Reactive oxygen species and protein oxidation in aging: A look back, a look ahead. Arch Biochem Biophys 397:377-383. (Pubitemid 34852306)
4. Halliwell B (1991) Drug antioxidant effects. A basis for drug selection? Drugs 42:569-605.
5. Slemmer JE, Shacka JJ, Sweeney MI, Weber JT (2008) Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr Med Chem 15:404-414.
6. Diener HC, et al. (2008) NXY-059 for the treatment of acute stroke: Pooled analysis of the SAINT I and II Trials. Stroke (Dallas) 39:1751-1758.
7. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. J Am Med Assoc 297:842-857. (Pubitemid 46333949)
8. Sesso HD, et al. (2008) Vitamins E and C in the prevention of cardiovascular disease in men: The Physicians' Health Study II randomized controlled trial. J Am Med Assoc 300:2123-2133.
9. Vincent AM, Edwards JL, Sadidi M, Feldman EL (2008) The antioxidant response as a drug target in diabetic neuropathy. Curr Drug Targets 9:94-100. (Pubitemid 351201684)
10. Schreibelt G, et al. (2007) Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev 56:322-330. (Pubitemid 350166526)
11. Crawford DR, Davies KJ (1994) Adaptive response and oxidative stress. Environ Health Perspect 102 Suppl 10:25-28.
12. Osburn WO, Kensler TW (2008) Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insults. Mutat Res 659:31-39.
13. Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89-116. (Pubitemid 46272125)
14. Lee JM, et al. (2005) Nrf2, a multi-organ protector? FASEB J 19:1061-1066.
15. Wakabayashi N, et al. (2004) Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 101:2040-2045. (Pubitemid 38229011)
16. Hong F, Freeman ML, Liebler DC (2005) Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem Res Toxicol 18:1917-1926. (Pubitemid 43023050)
17. Liby K, et al. (2005) The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res 65:4789-4798. (Pubitemid 40740817)
18. Juge N, Mithen RF, Traka M (2007) Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64:1105-1127. (Pubitemid 46684547)
19. Wang XJ, et al. (2008) Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29:1235-1243.
20. Brown NM, Torres AS, Doan PE, O'Halloran TV (2004) Oxygen and the copper chaperone CCS regulate posttranslational activation of Cu,Zn superoxide dismutase. Proc Natl Acad Sci USA 101:5518-5523.
21. Gusarov I, Nudler E (2005) NO-mediated cytoprotection: instant adaptation to oxidative stress in bacteria. Proc Natl Acad Sci USA 102:13855-13860. (Pubitemid 41377668)
22. Tsuji Y, et al. (2000) Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol 20:5818-5827. (Pubitemid 30613031)
23. Ufer C, et al. (2008) Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development. Genes Dev 22:1838-1850. (Pubitemid 351915508)
24. Shi ZZ, et al. (2000) Glutathione synthesis is essential for mouse development but not for cell growth in culture. Proc Natl Acad Sci USA 97:5101-5106.
25. Rojas E, et al. (2003) Cell survival and changes in gene expression in cells unable to synthesize glutathione. Biofactors 17:13-19. (Pubitemid 37267137)
26. Koller-Eichhorn R, et al. (2007) Human OLA1 defines an ATPase subfamily in the Obg family of GTP-binding proteins. J Biol Chem 282:19928-19937. (Pubitemid 47100072)
27. Simpson JC, Wellenreuther R, Poustka A, Pepperkok R, Wiemann S (2000) Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep 1:287-292.
28. Lee J, et al. (1999) Yap1 and Skn7 control two specialized oxidative stress response regulons in yeast. J Biol Chem 274:16040-16046. (Pubitemid 129526348)
29. Dierickx PJ, Nuffel GV, Alvarez I (1999) Glutathione protection against hydrogen peroxide, tert-butyl hydroperoxide and diamide cytotoxicity in rat hepatoma-derived Fa32 cells. Hum Exp Toxicol 18:627-633.
30. Alia M, Ramos S, Mateos R, Bravo L, Goya L (2005) Response of the antioxidant defense system to tert-butyl hydroperoxide and hydrogen peroxide in a human hepatoma cell line (HepG2). J Biochem Mol Toxicol 19:119-128. (Pubitemid 40571692)
31. Hedley DW, Chow S (1994) Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 15:349-358. (Pubitemid 24122417)
32. Chiang KP, Niessen S, Saghatelian A, Cravatt BF (2006) An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. Chem Biol 13:1041-1050. (Pubitemid 44557068)
33. Ursini MV, Parrella A, Rosa G, Salzano S, Martini G (1997) Enhanced expression of glucose-6-phosphate dehydrogenase in human cells sustaining oxidative stress. Biochem J 323 (Pt 3):801-806. (Pubitemid 27202352)
34. Legros F, Lombès A, Frachon P, Rojo M (2002) Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. Mol Biol Cell 13:4343-4354. (Pubitemid 35471190)
35. Park K, et al. (2005) Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis. Cancer Res 65:749-757. (Pubitemid 40216432)
36. Gradia DF, et al. (2009) Characterization of a novel Obg-like ATPase in the protozoan Trypanosoma cruzi. Int J Parasitol 39:49-58.
37. Guerrero C, Tagwerker C, Kaiser P, Huang L (2006) An integrated mass spectrometry-based proteomic approach: quantitative analysis of tandem affinity-purified in vivo cross-linked protein complexes (QTAX) to decipher the 26 S proteasome-interacting network. Mol Cell Proteomics 5:366-378. (Pubitemid 43329314)
38. Guerrero C, Milenkovic T, Przulj N, Kaiser P, Huang L (2008) Characterization of the proteasome interaction network using a QTAX-based tag-team strategy and protein interaction network analysis. Proc Natl Acad Sci USA 105:13333-13338.
39. Wang X, Huang L (2008) Identifying dynamic interactors of protein complexes by quantitative mass spectrometry. Mol Cell Proteomics 7:46-57. (Pubitemid 351248233)
40. Stocker R, Perrella MA (2006) Heme oxygenase-1: A novel drug target for atherosclerotic diseases? Circulation 114:2178-2189. (Pubitemid 44747899)
41. Arrigo AP, et al. (2007) Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett 581:3665-3674.
42. Chene P (2002) ATPases as drug targets: Learning from their structure. Nat Rev Drug Discov 1:665-673.